Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schey

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 4, 2012
Lymphadenopathy and splenomegaly in an HIV-infected manS A Winchester, R S Tedder, S Pomplun, et al.
British Journal of Clinical Pharmacology|April 1, 1990
Effects of a selective thromboxane receptor antagonist (GR32191B) and of glyceryl trinitrate on bleeding time in manJ M Ritter, N Benjamin, H S Doktor, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1989
The prognostic influence of mediastinal bulk in pathological stage IIA Hodgkin's disease treated initially with radiotherapyS Schey, B Vaughan Hudson, D C Linch, et al.
International Journal of Laboratory Hematology|November 20, 2008
United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myelomaF Davies, C Morris, J Bird, et al.
British Journal of Haematology|December 1, 1983
Allogeneic bone marrow transplantation: the monitoring of granulocyte macrophage colonies following the collection of bone marrow mononuclear cells and after the subsequent in-vitro cytolysis of OKT3 positive lymphocytesM J Gilmore, H G Prentice, E P Jones, et al.
Annals of Hematology|March 17, 2010
Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myelomaA Palumbo, F Davies, M Kropff, et al.
Bone Marrow Transplantation|June 26, 2007
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR studyS Feyler, H M Prince, R Pearce, et al.
Bone Marrow Transplantation|April 13, 2022
Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective optionI Lazana, L Floro, T Christmas, et al.
Leukemia & Lymphoma|November 9, 2001
Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphomaN C McBride, J D Cavenagh, M C Ward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prospective randomised study of double hemi-body irradiation with and without subsequent maintenance recombinant alpha 2b interferon on survival in patients with relapsed multiple myelomaF J Giles, E N McSweeney, J D Richards, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 4, 2012
Lymphadenopathy and splenomegaly in an HIV-infected manS A Winchester, R S Tedder, S Pomplun, et al.
British Journal of Clinical Pharmacology|April 1, 1990
Effects of a selective thromboxane receptor antagonist (GR32191B) and of glyceryl trinitrate on bleeding time in manJ M Ritter, N Benjamin, H S Doktor, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1989
The prognostic influence of mediastinal bulk in pathological stage IIA Hodgkin's disease treated initially with radiotherapyS Schey, B Vaughan Hudson, D C Linch, et al.
International Journal of Laboratory Hematology|November 20, 2008
United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myelomaF Davies, C Morris, J Bird, et al.
British Journal of Haematology|December 1, 1983
Allogeneic bone marrow transplantation: the monitoring of granulocyte macrophage colonies following the collection of bone marrow mononuclear cells and after the subsequent in-vitro cytolysis of OKT3 positive lymphocytesM J Gilmore, H G Prentice, E P Jones, et al.
Annals of Hematology|March 17, 2010
Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myelomaA Palumbo, F Davies, M Kropff, et al.
Bone Marrow Transplantation|June 26, 2007
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR studyS Feyler, H M Prince, R Pearce, et al.
Bone Marrow Transplantation|April 13, 2022
Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective optionI Lazana, L Floro, T Christmas, et al.
Leukemia & Lymphoma|November 9, 2001
Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphomaN C McBride, J D Cavenagh, M C Ward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prospective randomised study of double hemi-body irradiation with and without subsequent maintenance recombinant alpha 2b interferon on survival in patients with relapsed multiple myelomaF J Giles, E N McSweeney, J D Richards, et al.
Pageof 4